ATE296640T1 - Methode und mittel zur behandlung eines post- poliosyndroms - Google Patents

Methode und mittel zur behandlung eines post- poliosyndroms

Info

Publication number
ATE296640T1
ATE296640T1 AT00925790T AT00925790T ATE296640T1 AT E296640 T1 ATE296640 T1 AT E296640T1 AT 00925790 T AT00925790 T AT 00925790T AT 00925790 T AT00925790 T AT 00925790T AT E296640 T1 ATE296640 T1 AT E296640T1
Authority
AT
Austria
Prior art keywords
poliosyndrome
globulin
pps
treating post
gamma
Prior art date
Application number
AT00925790T
Other languages
English (en)
Inventor
Henrik Gonzalez
Kristian Borg
Original Assignee
Xepol Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xepol Ab filed Critical Xepol Ab
Application granted granted Critical
Publication of ATE296640T1 publication Critical patent/ATE296640T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Color Electrophotography (AREA)
AT00925790T 1999-04-01 2000-03-30 Methode und mittel zur behandlung eines post- poliosyndroms ATE296640T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/285,125 US6071516A (en) 1999-04-01 1999-04-01 Treatment of Post-Polio Syndrome with gamma-globulin
PCT/SE2000/000619 WO2000059539A1 (en) 1999-04-01 2000-03-30 Method and means for treating post-polio syndrome

Publications (1)

Publication Number Publication Date
ATE296640T1 true ATE296640T1 (de) 2005-06-15

Family

ID=23092831

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00925790T ATE296640T1 (de) 1999-04-01 2000-03-30 Methode und mittel zur behandlung eines post- poliosyndroms

Country Status (11)

Country Link
US (1) US6071516A (de)
EP (1) EP1171160B1 (de)
JP (1) JP4226789B2 (de)
AT (1) ATE296640T1 (de)
AU (1) AU772499B2 (de)
CA (1) CA2368184C (de)
DE (1) DE60020550T2 (de)
ES (1) ES2243257T3 (de)
NZ (1) NZ514490A (de)
PT (1) PT1171160E (de)
WO (1) WO2000059539A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008156418A1 (en) * 2007-06-19 2008-12-24 Astrazeneca Ab A method for screening or diagnosis of postpolio syndrome and fibromyalgia
CA3151943A1 (en) * 2019-11-04 2021-05-14 Viktoria Kheifets Blood plasma fractions for use in muscle regeneration

Also Published As

Publication number Publication date
CA2368184A1 (en) 2000-10-12
EP1171160B1 (de) 2005-06-01
CA2368184C (en) 2012-05-08
AU4442500A (en) 2000-10-23
AU772499B2 (en) 2004-04-29
DE60020550T2 (de) 2006-04-27
PT1171160E (pt) 2005-09-30
JP2002541121A (ja) 2002-12-03
DE60020550D1 (de) 2005-07-07
NZ514490A (en) 2004-01-30
JP4226789B2 (ja) 2009-02-18
EP1171160A1 (de) 2002-01-16
ES2243257T3 (es) 2005-12-01
US6071516A (en) 2000-06-06
WO2000059539A1 (en) 2000-10-12

Similar Documents

Publication Publication Date Title
NO20014842L (no) Docetaksel i kombinasjon med rhuMAb HER2 for behandling av kreft
IL195723A (en) Use of p53 inhibitors for the preparation of medicament
ATE316786T1 (de) Behandlung von mukositis
DE60138547D1 (de) Topisch anwendbare arzneipräparate und verfahren zur behandlung
DK1373215T3 (da) Gelanamycinderivater egnet til behandling af cancer
ATE375341T1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
UA88270C2 (ru) Фармацевтический препарат и его применение для профилактики удара, диабета
WO2005058233A3 (en) Methods for treatment of acute pancreatitis
SE9603725D0 (sv) New teatment
DE60214527D1 (de) Verwendung von flumazenil bei der entwicklung eines arzneimittels zur behandlung von alkoholabhängigkeit
DE60308679D1 (de) Methode zur behandlung oder prävention immunologischer erkrankungen und pharmazeutische zusammensetzung zur solchen anwendung
DE69935526D1 (de) Supramolekulare komplexe enthaltende arzneimittel
ATE310509T1 (de) Methode zur behandlung eines analgesiebedürftigen patienten
BR0007452A (pt) Uso de melagatrano ou de um derivado farmaceuticamente aceitável ou pró-droga do mesmo, método de tratamento de inflamação, e, formulação farmacêutica para uso no tratamento de inflamação
JO3446B1 (ar) طريقة لمعالجة الأرق الأولي
SE9902597D0 (sv) New use
DE69822810D1 (de) Somatostatin und somatostatin agoniste zur behandlung der insulinsunempfindlichkeit und syndrome x
MX2022011188A (es) Derivado biciclico fusionado, metodo de preparacion y uso farmaceutico del mismo.
ATE296640T1 (de) Methode und mittel zur behandlung eines post- poliosyndroms
SE0102887D0 (sv) New formulation
DE69733321D1 (de) Olanzapine zur behandlung von drogenmissbrauch
WO2004043486A8 (en) An acqueous pharmaceutical formulation comprising the thrombin inhibitor melagatran and use of the formulation in the manufacture of a medicament for use by nasal administration in treating thromboembolism
DE60121978D1 (de) 7-CHLOR-4-HYDROXY-2-(2-PYRIDYLETHYL)-1,2,5,10-TETRAHYDROPYRIDAZINOi4,5-BöCHINOLIN-1,10-DIONE UND IHRE VERWENDUNG ZUR BEHANDLUNG VON SCHMERZEN
DE60024408D1 (de) Verwendung von trizyklischen antidepressiva zur behandlung von kopfschmerzen
BR0016654A (pt) Composto, método para o tratamento da dor, e, composição farmacêutica

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties